Asabys, BPI France, Ysios in €30m series-A for Ona Therapeutics

Asabys, BPI France, Ysios in €30m series-A for Ona Therapeutics

Asabys Partners, alongside Alta Life Sciences, BPI France, Fund+ and Ysios Capital Partners, have invested in a €30m series-A round for drug development company Ona Therapeutics.

Read Previous

Zamo invests in SASC

Read Next

IQ appoints Hirtzel as general partner

Most Popular

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.